MZEI - Medizone International, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue237197-
Cost of Revenue203.46114.811-
Gross Profit33.5482.189-
Operating Expenses
Research Development501.734299.649420.945
Selling General and Administrative2,068.3911,737.1751,445.049
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-2,592.896-2,008.077-1,915.264
Income from Continuing Operations
Total Other Income/Expenses Net-47.090.0270.027
Earnings Before Interest and Taxes-2,639.986-2,008.05-1,915.264
Interest Expense33.8527.87225.176
Income Before Tax-2,673.836-2,035.922-1,940.44
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-2,673.836-2,035.922-1,940.44
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-2,673.836-2,035.922-1,940.44
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-2,673.836-2,035.922-1,940.44